Moleculin Reports Third Quarter 2023 Financial Results

Go back to Moleculin Reports Third Quarter 2023 Financial Results
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 0.63 +0.02 (3.28%)
Previous Close $0.61    52 Week High $9.58 
Open $0.63    52 Week Low $2.34 
Day High $0.64    P/E N/A 
Day Low $0.56    EPS $-0.34 
Volume 318,221